litlas
Log inCreate account

Lynette M. Sholl

Active 2007–2025

233
Papers
36,599
Citations
97
h-index
220
i10-index

Citations

Citations per year for Lynette M. Sholl1971: 1 citations1976: 1 citations1993: 2 citations2000: 6 citations2001: 1 citations2002: 2 citations2003: 1 citations2004: 1 citations2007: 1 citations2008: 3 citations2009: 3 citations2010: 20 citations2011: 35 citations2012: 28 citations2013: 58 citations2014: 78 citations2015: 152 citations2016: 282 citations2017: 299 citations2018: 395 citations2019: 1,275 citations2020: 1,770 citations2021: 2,096 citations2022: 1,906 citations2023: 1,641 citations2024: 2,571 citations2025: 1,528 citations2026: 104 citations1972–1975: no citations, so these years are not shown1977–1992: no citations, so these years are not shown1994–1999: no citations, so these years are not shown2005–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,856 citing papers, 25.7% of this breakdownChina: 3,066 citing papers, 16.2% of this breakdownItaly: 1,117 citing papers, 5.9% of this breakdownUnited Kingdom: 952 citing papers, 5% of this breakdownGermany: 753 citing papers, 4% of this breakdownJapan: 747 citing papers, 4% of this breakdownFrance: 694 citing papers, 3.7% of this breakdownCanada: 622 citing papers, 3.3% of this breakdownSpain: 612 citing papers, 3.2% of this breakdownNetherlands: 433 citing papers, 2.3% of this breakdownSouth Korea: 426 citing papers, 2.3% of this breakdownSwitzerland: 417 citing papers, 2.2% of this breakdown
0%25.7%Other 22.2%

Institutions

Fields

  • Medicine69%
  • Biochemistry, Genetics and Molecular Biology22.3%
  • Immunology and Microbiology4.2%
  • Computer Science2%
  • Engineering1%
  • Neuroscience0.3%
  • Other1.2%

Topics

  • Cancer Immunotherapy and Biomarkers9.6%
  • Lung Cancer Treatments and Mutations9.1%
  • Cancer Genomics and Diagnostics5.3%
  • Lung Cancer Research Studies4.1%
  • Lung Cancer Diagnosis and Treatment3.5%
  • Immunotherapy and Immune Responses2.1%
  • Other66.3%

Coauthors

All papers

Open in search
  1. PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    Authors: Deborah B. Doroshow, Sheena Bhalla, Mary Beth Beasley, Lynette M. Sholl, Keith M. Kerr, Sacha Gnjatic, Ignacio I. Wistuba, David L. Rimm, Ming‐Sound Tsao, Fred R. Hirsch - Nature Reviews Clinical Oncology 2021 cited by 1,560

  2. Acquired Resistance to KRAS G12C Inhibition in Cancer

    Authors: Mark M. Awad, Shengwu Liu, Igor I. Rybkin, Kathryn C. Arbour, Julien Dilly, Viola W. Zhu, Melissa L. Johnson, Rebecca S. Heist, Tejas Patil, Gregory J. Riely, Joseph O. Jacobson, Xiaoping Yang, Nicole S. Persky, David E. Root, Kristen E. Lowder, Hanrong Feng, Shannon S. Zhang, Kevin M. Haigis, Yin P. Hung, Lynette M. Sholl, Brian M. Wolpin, Julie Wiese, Jason Christiansen, Jessica Lee, Alexa B. Schrock, Lee P. Lim, Kavita Garg, Mark Li, Lars D. Engstrom, Laura Waters, J. David Lawson, Peter Olson, Piro Lito, Sai-Hong I. Ou, James G. Christensen, Pasi A. Jänne, Andrew J. Aguirre - New England Journal of Medicine 2021 cited by 1,164

  3. A pathology foundation model for cancer diagnosis and prognosis prediction

    Authors: Xiyue Wang, Junhan Zhao, Eliana Marostica, Wei Yuan, Jietian Jin, Jiayu Zhang, Ruijiang Li, Hongping Tang, Kanran Wang, Yu Li, Fang Wang, Yulong Peng, Junyou Zhu, Jing Zhang, Christopher Jackson, Jun Zhang, Deborah Dillon, Nancy U. Lin, Lynette M. Sholl, Thomas Denize, David M. Meredith, Keith L. Ligon, Sabina Signoretti, Shuji Ogino, Jeffrey A. Golden, MacLean P. Nasrallah, Xiao Han, Sen Yang, Kun‐Hsing Yu - Nature 2024 cited by 430

  4. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

    Authors: Andrew G. Nicholson, Ming‐Sound Tsao, Mary Beth Beasley, Alain Borczuk, Élisabeth Brambilla, Wendy A. Cooper, Sanja Đačić, Deepali Jain, Keith M. Kerr, Sylvie Lantuéjoul, Masayuki Noguchi, Mauro Papotti, Natasha Rekhtman, Giorgio V. Scagliotti, Paul Van Schil, Lynette M. Sholl, Yasushi Yatabe, Akihiko Yoshida, William D. Travis - Journal of Thoracic Oncology 2021 cited by 1,481

  5. STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

    Authors: Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad, Justin F. Gainor, Alexa B. Schrock, Ryan J. Hartmaier, Sally E. Trabucco, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin, Gaurav Singal, Jeffrey S. Ross, David Fabrizio, Péter M. Szabó, Chang Han, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph D. Szustakowski, Patrik Vitazka, Robin Edwards, José A. Bufill, Neelesh Sharma, Sai‐Hong Ignatius Ou, Nir Peled, David R. Spigel, Hira Rizvi, Elizabeth Jiménez Aguilar, Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach - Cancer Discovery 2018 cited by 1,604

  6. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    Authors: Christian Rolfo, Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlési, Trever G. Bivona, Maximilian Diehn, Caroline Dive, Rafał Dziadziuszko, Natasha B. Leighl, Umberto Malapelle, Tony Mok, Nir Peled, Luis E. Raez, Lecia V. Sequist, Lynette M. Sholl, Charles Swanton, Chris Abbosh, Daniel S.W. Tan, Heather A. Wakelee, Ignacio I. Wistuba, Rebecca A. Bunn, Janet Freeman‐Daily, Murry W. Wynes, Chandra P. Belani, Tetsuya Mitsudomi, David R. Gandara - Journal of Thoracic Oncology 2021 cited by 645

  7. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

    Authors: Biagio Ricciuti, Kathryn C. Arbour, W. Marston Linehan, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong, Jianjun Zhang, Michael Tolstorukov, Yvonne Y. Li, Liam F. Spurr, Andrew D. Cherniack, Gonzalo Recondo, Giuseppe Lamberti, Xinan Wang, Deepti Venkatraman, Joao V. Alessi, Victor R. Vaz, Hira Rizvi, Jacklynn V. Egger, Andrew J. Plodkowski, S. Khosrowjerdi, Subba R. Digumarthy, Hyesun Park, Nuno Vaz, Mizuki Nishino, Lynette M. Sholl, David A. Barbie, Mehmet Altan, John V. Heymach, Ferdinandos Skoulidis, Justin F. Gainor, Matthew D. Hellmann, Mark M. Awad - Journal of Thoracic Oncology 2021 cited by 367

  8. Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels

    Authors: Biagio Ricciuti, Xinan Wang, Joao V. Alessi, Hira Rizvi, Navin R. Mahadevan, Yvonne Y. Li, Andrew Polio, James Lindsay, Renato Umeton, Rileen Sinha, Natalie I. Vokes, Gonzalo Recondo, Giuseppe Lamberti, Marissa Lawrence, Victor R. Vaz, Giulia C. Leonardi, Andrew J. Plodkowski, Hersh Gupta, Andrew D. Cherniack, Michael Tolstorukov, Bijaya Sharma, Kristen D. Felt, Justin F. Gainor, Arvind Ravi, Gad Getz, Kurt A. Schalper, Brian S. Henick, Patrick M. Forde, Valsamo Anagnostou, Pasi A. Jänne, Eliezer M. Van Allen, Mizuki Nishino, Lynette M. Sholl, David C. Christiani, Xihong Lin, Scott J. Rodig, Matthew D. Hellmann, Mark M. Awad - JAMA Oncology 2022 cited by 384

  9. Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer

    Authors: Shunsuke Kitajima, Elena V. Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K. Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C. Thai, Sayuri Masuda, Brandon Piel, Lynette M. Sholl, Paul T. Kirschmeier, Cloud P. Paweletz, Hideo Watanabe, Mamiko Yajima, David A. Barbie - Cancer Discovery 2018 cited by 515

  10. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    Authors: André L. Moreira, Paolo Ocampo, Yuhe Xia, Judy Zhong, Prudence A. Russell, Yuko Minami, Wendy A. Cooper, Akihiko Yoshida, Lukas Bubendorf, Mauro Papotti, Giuseppe Pelosi, Fernando López‐Ríos, Keiko Kunitoki, Dana Ferrari‐Light, Lynette M. Sholl, Mary Beth Beasley, Alain Borczuk, Johan Botling, Élisabeth Brambilla, Gang Chen, Teh‐Ying Chou, Jin-Haeng Chung, Sanja Đačić, Deepali Jain, Fred R. Hirsch, David Hwang, Sylvie Lantuéjoul, Dongmei Lin, John Longshore, Noriko Motoi, Masayuki Noguchi, Claudia Poleri, Natasha Rekhtman, Ming‐Sound Tsao, Erik Thunnissen, William D. Travis, Yasushi Yatabe, Anja C. Roden, Jillian B. Daigneault, Ignacio I. Wistuba, Keith M. Kerr, Harvey I. Pass, Andrew G. Nicholson, Mari Mino–Kenudson - Journal of Thoracic Oncology 2020 cited by 541

  11. Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases

    Authors: Ilya Korsunsky, Kevin Wei, Mathilde Pohin, Edy Y. Kim, Francesca Barone, Triin Major, Emily Taylor, Rahul Ravindran, Samuel Kemble, Gerald F. Watts, A. Helena Jonsson, Yunju Jeong, Humra Athar, Dylan Windell, Joyce B. Kang, Matthias Friedrich, Jason D. Turner, Saba Nayar, Benjamin A. Fisher, Karim Raza, Jennifer L. Marshall, Adam P. Croft, Tomoyoshi Tamura, Lynette M. Sholl, Marina Vivero, Iván O. Rosas, Simon Bowman, Mark Coles, Andreas P. Frei, Kara G. Lassen, Andrew Filer, Fiona Powrie, Christopher D. Buckley, Michael B. Brenner, Soumya Raychaudhuri - Med 2022 cited by 224

  12. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer

    Authors: Elizabeth Garcia, Alissa Minkovsky, Yonghui Jia, Matthew D. Ducar, Priyanka Shivdasani, Xin Gong, Azra H. Ligon, Lynette M. Sholl, Frank C. Kuo, Laura E. MacConaill, Neal I. Lindeman, Fei Dong - Archives of Pathology & Laboratory Medicine 2017 cited by 522

  13. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    Authors: William D. Travis, Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf, Paul A. Bunn, Tina Cascone, Jamie E. Chaft, Gang Chen, Teh‐Ying Chou, Wendy A. Cooper, Jeremy J. Erasmus, Carlos Gil Ferreira, Jin-Mo Goo, John V. Heymach, Fred R. Hirsch, Hidehito Horinouchi, Keith M. Kerr, Mark G. Kris, Deepali Jain, Young Tae Kim, Fernando López‐Ríos, Shun Lü, Tetsuya Mitsudomi, André Moreira, Noriko Motoi, Andrew G. Nicholson, Ricardo Oliveira, Mauro Papotti, Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe - Journal of Thoracic Oncology 2020 cited by 450

  14. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

    Authors: Navin R. Mahadevan, Erik H. Knelson, Jacquelyn O. Wolff, Amir Vajdi, Maria Saigí, Marco Campisi, Deli Hong, Tran C. Thai, Brandon Piel, Saemi Han, Bruce B. Reinhold, Jonathan S. Duke‐Cohan, Michael J. Poitras, Luke J. Taus, Patrick H. Lizotte, Andrew Portell, Victor Quadros, Alison Santucci, Takahiko Murayama, Israel Cañadas, Shunsuke Kitajima, Aoi Akitsu, Maya Fridrikh, Hideo Watanabe, Brendan Reardon, Prafulla C. Gokhale, Cloud P. Paweletz, Mark M. Awad, Eliezer M. Van Allen, Ana Lako, Xitao Wang, Bowen Chen, Fangxin Hong, Lynette M. Sholl, Michael Tolstorukov, Kathleen L. Pfaff, Pasi A. Jänne, Evisa Gjini, Robin Edwards, Scott J. Rodig, Ellis L. Reinherz, Matthew G. Oser, David A. Barbie - Cancer Discovery 2021 cited by 214

  15. Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

    Authors: Esra A. Akbay, Shohei Koyama, Julián Carretero, Abigail Altabef, Jeremy H. Tchaicha, Camilla L. Christensen, Oliver R. Mikse, Andrew D. Cherniack, Ellen M. Beauchamp, Trevor J. Pugh, Matthew D. Wilkerson, Peter E. Fecci, Mohit Butaney, Jacob B. Reibel, Margaret Soucheray, Travis J. Cohoon, Pasi A. Jänne, Matthew Meyerson, D. Neil Hayes, Geoffrey I. Shapiro, Takeshi Shimamura, Lynette M. Sholl, Scott J. Rodig, Gordon J. Freeman, Peter S. Hammerman, Glenn Dranoff, Kwok‐Kin Wong - Cancer Discovery 2013 cited by 1,242

  16. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Authors: Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric Bernicker, Carol Colasacco, Sanja Đačić, Fred R. Hirsch, Keith M. Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette M. Sholl, Robyn Temple‐Smolkin, Benjamin Solomon, Lesley Souter, Erik Thunnissen, Ming‐Sound Tsao, Christina B. Ventura, Murry W. Wynes, Yasushi Yatabe - Archives of Pathology & Laboratory Medicine 2018 cited by 931

  17. Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

    Authors: Geoffrey R. Oxnard, Yuebi Hu, Kathryn F. Mileham, Hatim Husain, Daniel B. Costa, Philip Tracy, Nora Feeney, Lynette M. Sholl, Suzanne E. Dahlberg, Amanda J. Redig, David J. Kwiatkowski, Michael S. Rabin, Cloud P. Paweletz, Kenneth S. Thress, Pasi A. Jänne - JAMA Oncology 2018 cited by 689

  18. MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

    Authors: Mark M. Awad, Geoffrey R. Oxnard, David M. Jackman, Daniel O. Savukoski, Dimity Hall, Priyanka Shivdasani, Jennifer Heng, Suzanne E. Dahlberg, Pasi A. Jänne, Suman Verma, James G. Christensen, Peter S. Hammerman, Lynette M. Sholl - Journal of Clinical Oncology 2016 cited by 688

  19. Association of clonal hematopoiesis with chronic obstructive pulmonary disease

    Authors: Peter G. Miller, Dandi Qiao, Joselyn Rojas, Michael C. Honigberg, Adam S. Sperling, Christopher J. Gibson, Alexander G. Bick, Abhishek Niroula, Marie McConkey, Brittany Sandoval, Brian C. Miller, Weiwei Shi, Kaushik Viswanathan, Matthew Leventhal, Lillian Werner, Matthew Moll, Brian E. Cade, R. Graham Barr, Adolfo Correa, L. Adrienne Cupples, Sina A. Gharib, Deepti Jain, Stephanie M. Gogarten, Leslie A. Lange, Stephanie J. London, Ani Manichaikul, George O'connor, Elizabeth C. Oelsner, Susan Redline, Stephen S. Rich, Jerome I. Rotter, Ramachandran S. Vasan, Bing Yu, Lynette M. Sholl, Donna Neuberg, Siddhartha Jaiswal, Bruce D. Levy, Caroline A. Owen, Pradeep Natarajan, Edwin K. Silverman, Peter van Galen, Yohannes Tesfaigzi, Michael H. Cho, Benjamin L. Ebert - Blood 2021 cited by 229

  20. Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

    Authors: Esther Aguilar, Biagio Ricciuti, Justin F. Gainor, Kenneth L. Kehl, Sasha Kravets, Suzanne E. Dahlberg, Mizuki Nishino, Lynette M. Sholl, Anika E. Adeni, S. Subegdjo, S. Khosrowjerdi, Rachel Peterson, Subba R. Digumarthy, C. Liu, Jennifer L. Sauter, Hira Rizvi, Kathryn C. Arbour, B.W. Carter, John V. Heymach, Mehmet Altan, Matthew D. Hellmann, Mark M. Awad - Annals of Oncology 2019 cited by 336

  21. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

    Authors: Mari Mino–Kenudson, Kurt A. Schalper, Wendy A. Cooper, Sanja Đačić, Fred R. Hirsch, Deepali Jain, Fernando López‐Ríos, Ming‐Sound Tsao, Yasushi Yatabe, Mary Beth Beasley, Hui Yu, Lynette M. Sholl, E. Brambilla, Teh‐Ying Chou, Casey Connolly, Ignacio I. Wistuba, Keith M. Kerr, Sylvie Lantuéjoul - Journal of Thoracic Oncology 2022 cited by 215

  22. Association of Machine Learning–Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC

    Authors: Mehrdad Rakaee, Elio Adib, Biagio Ricciuti, Lynette M. Sholl, Weiwei Shi, Joao V. Alessi, Alessio Cortellini, Claudia Angela Maria Fulgenzi, Patrizia Viola, David J. Pinato, Sayed M.S. Hashemi, Idris Bahce, Ilias Houda, Ezgi B Ulas, Teodora Radonic, Juha P. Väyrynen, Elin Richardsen, Simin Jamaly, Sigve Andersen, Tom Dønnem, Mark M. Awad, David J. Kwiatkowski - JAMA Oncology 2022 cited by 131

  23. Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary

    Authors: Intae Moon, Jaclyn LoPiccolo, Sylvan C. Baca, Lynette M. Sholl, Kenneth L. Kehl, Michael J. Hassett, David Liu, Deborah Schrag, Alexander Gusev - Nature Medicine 2023 cited by 112

  24. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

    Authors: Diana Miao, Claire A. Margolis, Natalie I. Vokes, David Liu, Amaro Taylor‐Weiner, Stephanie A. Wankowicz, Dennis O. Adeegbe, Daniel Keliher, Bastian Schilling, Adam Tracy, Michael P. Manos, Nicole G. Chau, Glenn J. Hanna, Paz Polak, Scott J. Rodig, Sabina Signoretti, Lynette M. Sholl, Jeffrey A. Engelman, Gad Getz, Pasi A. Jänne, Robert I. Haddad, Toni K. Choueiri, David A. Barbie, Rizwan Haq, Mark M. Awad, Dirk Schadendorf, F. Stephen Hodi, Joaquim Bellmunt, Kwok‐Kin Wong, Peter S. Hammerman, Eliezer M. Van Allen - Nature Genetics 2018 cited by 696